These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24752109)

  • 1. [Neuropad test for sudomotor function to predict the risk of diabetic foot ulceration].
    Qin Y; Cao Y; Gao F; Luo X; Li J; Fu X; Xue Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):560-2. PubMed ID: 24752109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study.
    Panagoulias GS; Eleftheriadou I; Papanas N; Manes C; Kamenov Z; Tesic D; Bousboulas S; Tentolouris A; Jude EB; Tentolouris N
    Front Endocrinol (Lausanne); 2020; 11():625. PubMed ID: 33013702
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
    Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice.
    Kamenov ZA; Petrova JJ; Christov VG
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):226-33. PubMed ID: 20200815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy.
    Spallone V; Morganti R; Siampli M; Fedele T; D'Amato C; Cacciotti L; Maiello MR
    Diabet Med; 2009 Jul; 26(7):686-92. PubMed ID: 19573117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination?
    Armstrong DG; Hussain SK; Middleton J; Peters EJ; Wunderlich RP; Lavery LA
    Ostomy Wound Manage; 1998 May; 44(5):70-4, 76. PubMed ID: 9697548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropad test in evaluation of diabetic foot].
    Vieru A; Niţă O; Graur LI; Mazilu G; Mihalache L; Popescu RM; Graur M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):90-6. PubMed ID: 23077878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes.
    Tentolouris N; Voulgari C; Liatis S; Kokkinos A; Eleftheriadou I; Makrilakis K; Marinou K; Katsilambros N
    Diabetes Care; 2010 May; 33(5):1112-4. PubMed ID: 20150296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients.
    Papanas N; Papatheodorou K; Christakidis D; Papazoglou D; Giassakis G; Piperidou H; Monastiriotis C; Maltezos E
    Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):195-8. PubMed ID: 15891953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study.
    Manes C; Papanas N; Exiara T; Katsiki N; Papantoniou S; Kirlaki E; Tsotoulidis S; Kefalogiannis N; Maltezos E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):195-9. PubMed ID: 24643697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting ulcer-free survival using the discriminative value of screening test locations.
    Rinkel WD; van der Oest MJW; Dijkstra DA; Castro Cabezas M; Coert JH
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3119. PubMed ID: 30575290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of peripheral arterial occlusive disease on the Neuropad(®) test performance in patients with diabetes.
    Aubert CE; Le Doeuff J; Lajou J; Barthelemy O; Hartemann A; Bourron O
    Diabet Med; 2013 May; 30(5):e178-84. PubMed ID: 23398465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
    Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
    J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Neuropad test in the screening of peripheral neuropathy in diabetic patients].
    Freitas C; Carvalho A; Melo-Rocha G; Amaral C; Pinto S; Guimarães R; Neto H; Suascun J; Muras J; Gonçalves I; Martins J; Dores J; Carvalho R; Borges F
    Acta Med Port; 2009; 22(6):729-34. PubMed ID: 20350454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of limited joint mobility and foot deformities with neurological examination in patients with diabetes.
    Sanz-Corbalán I; Lázaro-Martínez JL; García-Morales E; Aragón-Sánchez J; Carabantes-Alarcón D; García-Álvarez Y
    Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):239-43. PubMed ID: 23329582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated use of vibration perception thresholds and semmes-weinstein monofilament in diagnosing diabetic polyneuropathy: "the North Catalonia diabetes study".
    Jurado J; Ybarra J; Pou JM
    Nurs Clin North Am; 2007 Mar; 42(1):59-66. PubMed ID: 17270590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and comparison of currently available stratification systems for patients with diabetes by risk of foot ulcer development.
    Monteiro-Soares M; Vaz-Carneiro A; Sampaio S; Dinis-Ribeiro M
    Eur J Endocrinol; 2012 Sep; 167(3):401-7. PubMed ID: 22740504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.
    Richard JL; Reilhes L; Buvry S; Goletto M; Faillie JL
    Int Wound J; 2014 Apr; 11(2):147-51. PubMed ID: 22892021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sudomotor dysfunction diagnostic test for early detection of diabetic neuropathy].
    Lorenzini N; Díaz C; Quintana T
    Rev Med Chil; 2020 Jan; 148(1):54-59. PubMed ID: 32730436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
    Zografou I; Iliadis F; Sambanis C; Didangelos T
    Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.